Amit Bhalla

Citigroup

Recent Quotes

"TMO's positive 2012 financial trajectory should continue into 2013."

— Amit Bhalla, Citigroup (2/13/13)
more >

"EW should see greater benefits from a ramp-up in TAVI adoption."

— Amit Bhalla, Citigroup (12/4/12)
more >

"We maintain our Buy rating on EW."

— Amit Bhalla, Citigroup (4/19/12)
more >

"EW's Sapien/TAVI is one of the most significant new products in medtech."

— Amit Bhalla, Citigroup (4/12/12)
more >



Due to permission requirements, not all quotes are shown.